Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Persistence of meningococcal C seroprotection in adolescents after a single toddler MenC conjugate vaccine dose
2010-019091-78Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Apr 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of meningococcal serogroup C conjugate vaccine in invasive meningococcal disease (IMD), sponsored by University of Oxford. Started Apr 2010; status: completed.
02
Drugs
meningococcal serogroup C conjugate vaccine
03
Conditions
invasive meningococcal disease (IMD)
Beyond the preview
Go deeper on 2010-019091-78.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019091-78.